BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

420 related articles for article (PubMed ID: 23737295)

  • 1. CHO cell line specific prediction and control of recombinant monoclonal antibody N-glycosylation.
    Grainger RK; James DC
    Biotechnol Bioeng; 2013 Nov; 110(11):2970-83. PubMed ID: 23737295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic control of recombinant monoclonal antibody N-glycosylation in GS-NS0 cells.
    Hills AE; Patel A; Boyd P; James DC
    Biotechnol Bioeng; 2001 Oct; 75(2):239-51. PubMed ID: 11536148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of antibody galactosylation through feeding of uridine, manganese chloride, and galactose.
    Gramer MJ; Eckblad JJ; Donahue R; Brown J; Shultz C; Vickerman K; Priem P; van den Bremer ET; Gerritsen J; van Berkel PH
    Biotechnol Bioeng; 2011 Jul; 108(7):1591-602. PubMed ID: 21328321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The availability of glucose to CHO cells affects the intracellular lipid-linked oligosaccharide distribution, site occupancy and the N-glycosylation profile of a monoclonal antibody.
    Liu B; Spearman M; Doering J; Lattová E; Perreault H; Butler M
    J Biotechnol; 2014 Jan; 170():17-27. PubMed ID: 24286971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amino acid and glucose metabolism in fed-batch CHO cell culture affects antibody production and glycosylation.
    Fan Y; Jimenez Del Val I; Müller C; Wagtberg Sen J; Rasmussen SK; Kontoravdi C; Weilguny D; Andersen MR
    Biotechnol Bioeng; 2015 Mar; 112(3):521-35. PubMed ID: 25220616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zinc supplementation decreases galactosylation of recombinant IgG in CHO cells.
    Prabhu A; Gadre R; Gadgil M
    Appl Microbiol Biotechnol; 2018 Jul; 102(14):5989-5999. PubMed ID: 29749563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of sodium butyrate on the assembly, charge variants, and galactosylation of antibody produced in recombinant Chinese hamster ovary cells.
    Hong JK; Lee SM; Kim KY; Lee GM
    Appl Microbiol Biotechnol; 2014 Jun; 98(12):5417-25. PubMed ID: 24557571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nickel and cobalt affect galactosylation of recombinant IgG expressed in CHO cells.
    Prabhu A; Gadgil M
    Biometals; 2019 Feb; 32(1):11-19. PubMed ID: 30327978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional heterogeneity and heritability in CHO cell populations.
    Davies SL; Lovelady CS; Grainger RK; Racher AJ; Young RJ; James DC
    Biotechnol Bioeng; 2013 Jan; 110(1):260-74. PubMed ID: 22833427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A global RNA-seq-driven analysis of CHO host and production cell lines reveals distinct differential expression patterns of genes contributing to recombinant antibody glycosylation.
    Könitzer JD; Müller MM; Leparc G; Pauers M; Bechmann J; Schulz P; Schaub J; Enenkel B; Hildebrandt T; Hampel M; Tolstrup AB
    Biotechnol J; 2015 Sep; 10(9):1412-23. PubMed ID: 26212696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineering nucleotide sugar synthesis pathways for independent and simultaneous modulation of N-glycan galactosylation and fucosylation in CHO cells.
    Prabhu A; Shanmugam D; Gadgil M
    Metab Eng; 2022 Nov; 74():61-71. PubMed ID: 36152932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid whole monoclonal antibody analysis by mass spectrometry: An ultra scale-down study of the effect of harvesting by centrifugation on the post-translational modification profile.
    Reid CQ; Tait A; Baldascini H; Mohindra A; Racher A; Bilsborough S; Smales CM; Hoare M
    Biotechnol Bioeng; 2010 Sep; 107(1):85-95. PubMed ID: 20506289
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation and modeling of monoclonal antibody N-linked glycosylation in mammalian cell perfusion reactors.
    Karst DJ; Scibona E; Serra E; Bielser JM; Souquet J; Stettler M; Broly H; Soos M; Morbidelli M; Villiger TK
    Biotechnol Bioeng; 2017 Sep; 114(9):1978-1990. PubMed ID: 28409838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How does mild hypothermia affect monoclonal antibody glycosylation?
    Sou SN; Sellick C; Lee K; Mason A; Kyriakopoulos S; Polizzi KM; Kontoravdi C
    Biotechnol Bioeng; 2015 Jun; 112(6):1165-76. PubMed ID: 25545631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low glucose depletes glycan precursors, reduces site occupancy and galactosylation of a monoclonal antibody in CHO cell culture.
    Villacrés C; Tayi VS; Lattová E; Perreault H; Butler M
    Biotechnol J; 2015 Jul; 10(7):1051-66. PubMed ID: 26058832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fc galactosylation follows consecutive reaction kinetics and enhances immunoglobulin G hexamerization for complement activation.
    Wei B; Gao X; Cadang L; Izadi S; Liu P; Zhang HM; Hecht E; Shim J; Magill G; Pabon JR; Dai L; Phung W; Lin E; Wang C; Whang K; Sanchez S; Oropeza J; Camperi J; Zhang J; Sandoval W; Zhang YT; Jiang G
    MAbs; 2021; 13(1):1893427. PubMed ID: 33682619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of cell adaptation to serum-free conditions on the glycosylation profile of a monoclonal antibody produced by Chinese hamster ovary cells.
    Costa AR; Withers J; Rodrigues ME; McLoughlin N; Henriques M; Oliveira R; Rudd PM; Azeredo J
    N Biotechnol; 2013 Jun; 30(5):563-72. PubMed ID: 23247406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Media supplementation for targeted manipulation of monoclonal antibody galactosylation and fucosylation.
    Wells E; Song L; Greer M; Luo Y; Kurian V; Ogunnaike B; Robinson AS
    Biotechnol Bioeng; 2020 Nov; 117(11):3310-3321. PubMed ID: 32662879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Galactosylation variations in marketed therapeutic antibodies.
    Raju TS; Jordan RE
    MAbs; 2012; 4(3):385-91. PubMed ID: 22531450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Manganese increases high mannose glycoform on monoclonal antibody expressed in CHO when glucose is absent or limiting: Implications for use of alternate sugars.
    Surve T; Gadgil M
    Biotechnol Prog; 2015; 31(2):460-7. PubMed ID: 25504679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.